Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Abroad (travel likely)RecruitingPHASE4

Conditions

Acute Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Virginia Commonwealth University, Richmond, Virginia, United States
Contact: Study coordinator (Massey CTO Heme Team) · MasseyHemMlg@vcu.edu · 804-628-6430
Contact: Principal Investigator (Keri Maher, DO)

Study leads

Keri Maher, DO
Principal Investigator
Virginia Commonwealth University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Iowa City, United States

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE4

Hangzhou, China

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Lung Cancer (Diagnosis) · Osteochondroma · Spitz Nevus

Abroad (travel likely)Recruiting

Boston, United States